Transmedics Group Inc (TMDX)

HEALTH CARE: HEALTH CARE SUPPLIES
SIC: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS

200 MINUTEMAN ROAD ANDOVER, MA 01810

TransMedics is the world's leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered in Andover, Massachusetts, the company was founded to address the unmet need for more and better organs for transplantation and has developed technologies to preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung and liver failure.

Data as of 2021-09-11 11:54:54 -0400
Market Cap876.782 Million Shares Outstanding27.624 Million Avg 30-day Volume231.363 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS0
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-1.57 Enterprise Value
Total Cash Current Debt Gross Profit
BETA0.0 52-week High/Low49.5 / 11.51 Next Earnings Date2021-11-03 Price to Cash FLow (P/CF) -85.8886
Data provided by IEX Cloud
View SEC Filings from TMDX instead.

View recent insider trading info

Transmedics Group Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding TMDX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding TMDX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

21.2 Thousand total shares from 6 transactions

Exercise Derivative Conversion (M)

28.3 Thousand total shares from 7 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

PROVOST MIRIAM VP OF US REGULATORY & FDA REL.

  • Officer
 17,929 2021-09-15 4

KHAYAL TAMER I CHIEF COMMERCIAL OFFICER

  • Officer
 65,261 2021-09-07 5

GORDON STEPHEN CHIEF FINANCIAL OFFICER

  • Officer
 5,714 2021-09-07 9

CAREY JOHN F VP OF OPERATIONS

  • Officer
 15,633 2021-09-01 8

SULLIVAN JOHN F VP OF QUALITY & ENGINEERING

  • Officer
 30,045 2021-08-30 7

GODHANI RAKESH P. CHIEF DIGITAL OFFICER

  • Officer
 0 2021-08-04 2

RAINES MERILEE

  • Director
 2,250 2021-05-27 3

TOBIN JAMES R

  • Director
 13,500 2021-05-27 2

KANIA EDWIN M JR

  • Director
 13,500 2021-05-27 1

GUNDERSON THOMAS JAMES

  • Director
 13,500 2021-05-27 1

LOVELL STEPHANIE

  • Director
 2,250 2021-05-27 3

BASILE EDWARD M

  • Director
 13,500 2021-05-27 1

WEILL DAVID

  • Director
 13,500 2021-05-27 1

HASSANEIN WALEED H PRESIDENT & CEO

  • Officer
  • Director
 526,214 2021-04-05 5

DAMME LAURA VP, CLINICAL AFFAIRS

  • Officer
 25,000 2021-02-24 1

ABRAMS CAPITAL MANAGEMENT, L.P.

ABRAMS CAPITAL MANAGEMENT, LLC

ABRAMS CAPITAL PARTNERS II, L.P.

ABRAMS CAPITAL, LLC

ABRAMS DAVID C

RIVA CAPITAL PARTNERS III, L.P.

RIVA CAPITAL MANAGEMENT III, LLC

  • 10% Owner
 No longer subject to file 2021-02-08 1

UNITED THERAPEUTICS CORP

LUNG BIOTECHNOLOGY PBC

  • 10% Owner
 No longer subject to file 2019-12-09 0

FLAGSHIP VENTURES FUND IV GENERAL PARTNER LLC

FLAGSHIP VENTURES FUND IV, L.P.

FLAGSHIP VENTURES 2007 GENERAL PARTNER LLC

FLAGSHIP VENTURES FUND 2007, L.P.

AFEYAN NOUBAR

  • 10% Owner
 No longer subject to file 2019-10-29 0

GILBERT JAMES

  • Director
 0 2019-05-01 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

PROVOST MIRIAM - Officer VP OF US REGULATORY & FDA REL.

2021-09-17 16:34:16 -0400 2021-09-15 M 5,625 d 9,375 direct

PROVOST MIRIAM - Officer VP OF US REGULATORY & FDA REL.

2021-09-17 16:34:16 -0400 2021-09-15 S 3,877 $31.34 d 8,554 direct

PROVOST MIRIAM - Officer VP OF US REGULATORY & FDA REL.

2021-09-17 16:34:16 -0400 2021-09-15 M 5,625 $16.14 a 12,431 direct

KHAYAL TAMER I - Officer CHIEF COMMERCIAL OFFICER

2021-09-09 18:25:55 -0400 2021-09-07 M 3,941 d 19,185 direct yes

GORDON STEPHEN - Officer CHIEF FINANCIAL OFFICER

2021-09-09 18:14:32 -0400 2021-09-07 M 10,000 d 0 direct yes

KHAYAL TAMER I - Officer CHIEF COMMERCIAL OFFICER

2021-09-09 18:25:55 -0400 2021-09-07 S 3,941 $35.08 d 46,076 direct yes -2.804 -0.126 1.5438 5 -2.804 2

GORDON STEPHEN - Officer CHIEF FINANCIAL OFFICER

2021-09-09 18:14:32 -0400 2021-09-07 S 10,000 $35.00 d 5,714 direct yes -2.804 -0.126 1.5438 5 -2.804 2

KHAYAL TAMER I - Officer CHIEF COMMERCIAL OFFICER

2021-09-09 18:25:55 -0400 2021-09-07 M 3,941 $0.28 a 50,017 direct yes -2.804 -0.126 1.5438 5 -2.804 2

GORDON STEPHEN - Officer CHIEF FINANCIAL OFFICER

2021-09-09 18:14:32 -0400 2021-09-07 M 10,000 $0.67 a 15,714 direct yes -2.804 -0.126 1.5438 5 -2.804 2

CAREY JOHN F - Officer VP OF OPERATIONS

2021-09-03 17:14:23 -0400 2021-09-01 M 1,680 d 15,633 direct yes

CAREY JOHN F - Officer VP OF OPERATIONS

2021-09-03 17:14:23 -0400 2021-09-01 M 1,680 $2.21 a 1,680 direct yes -0.7547 -2.2327 0.9434 3 -2.9874 5

CAREY JOHN F - Officer VP OF OPERATIONS

2021-09-03 17:14:23 -0400 2021-09-01 S 600 $32.37 d 0 direct yes -0.7547 -2.2327 0.9434 3 -2.9874 5

CAREY JOHN F - Officer VP OF OPERATIONS

2021-09-03 17:14:23 -0400 2021-09-01 S 1,080 $31.77 d 600 direct yes -0.7547 -2.2327 0.9434 3 -2.9874 5

SULLIVAN JOHN F - Officer VP OF QUALITY & ENGINEERING

2021-09-01 17:04:44 -0400 2021-08-30 M 3,200 d 15,772 direct

SULLIVAN JOHN F - Officer VP OF QUALITY & ENGINEERING

2021-09-01 17:04:44 -0400 2021-08-30 M 3,200 $0.28 a 14,273 direct -2.7679 -5.5357 0.0 1 -6.0714 4

GODHANI RAKESH P. - Officer CHIEF DIGITAL OFFICER

2021-08-06 17:05:31 -0400 2021-08-04 A 140,000 a 140,000 direct

CAREY JOHN F - Officer VP OF OPERATIONS

2021-08-04 17:00:16 -0400 2021-08-02 M 1,680 $2.21 a 1,680 direct yes 8.4872 7.3864 12.571 19.3182 21 -7.9545 11

CAREY JOHN F - Officer VP OF OPERATIONS

2021-08-04 17:00:16 -0400 2021-08-02 M 1,680 d 17,313 direct yes

CAREY JOHN F - Officer VP OF OPERATIONS

2021-08-04 17:00:16 -0400 2021-08-02 S 1,680 $28.33 d 0 direct yes 8.4872 7.3864 12.571 19.3182 21 -7.9545 11

PROVOST MIRIAM - Officer VP OF US REGULATORY & FDA REL.

2021-08-03 17:00:35 -0400 2021-07-30 M 2,206 $3.22 a 6,806 direct 1.0405 6.9609 15.6441 20.5597 22 -6.9968 12

PROVOST MIRIAM - Officer VP OF US REGULATORY & FDA REL.

2021-08-03 17:00:35 -0400 2021-07-30 M 2,206 d 21,765 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
TRANSMEDICS GROUP INC TMDX 2021-09-17 22:15:03 UTC -0.18 0.25 650000
TRANSMEDICS GROUP INC TMDX 2021-09-17 21:45:03 UTC -0.18 0.25 650000
TRANSMEDICS GROUP INC TMDX 2021-09-17 21:15:04 UTC -0.18 0.25 650000
TRANSMEDICS GROUP INC TMDX 2021-09-17 20:45:03 UTC -0.18 0.25 650000
TRANSMEDICS GROUP INC TMDX 2021-09-17 20:15:05 UTC -0.18 0.25 650000
TRANSMEDICS GROUP INC TMDX 2021-09-17 19:45:03 UTC -0.18 0.25 650000
TRANSMEDICS GROUP INC TMDX 2021-09-17 19:15:03 UTC -0.18 0.25 650000
TRANSMEDICS GROUP INC TMDX 2021-09-17 18:45:03 UTC -0.18 0.25 650000
TRANSMEDICS GROUP INC TMDX 2021-09-17 18:15:03 UTC -0.18 0.25 650000
TRANSMEDICS GROUP INC TMDX 2021-09-17 17:45:03 UTC -0.18 0.25 650000
TRANSMEDICS GROUP INC TMDX 2021-09-17 17:15:03 UTC -0.18 0.25 650000
TRANSMEDICS GROUP INC TMDX 2021-09-17 16:45:03 UTC -0.18 0.25 650000
TRANSMEDICS GROUP INC TMDX 2021-09-17 16:15:02 UTC -0.18 0.25 650000
TRANSMEDICS GROUP INC TMDX 2021-09-17 15:45:02 UTC -0.18 0.25 650000
TRANSMEDICS GROUP INC TMDX 2021-09-17 15:15:03 UTC -0.18 0.25 650000
TRANSMEDICS GROUP INC TMDX 2021-09-17 14:45:03 UTC -0.1815 0.2515 650000
TRANSMEDICS GROUP INC TMDX 2021-09-17 14:15:03 UTC -0.1815 0.2515 650000
TRANSMEDICS GROUP INC TMDX 2021-09-17 13:45:02 UTC -0.1815 0.2515 650000
TRANSMEDICS GROUP INC TMDX 2021-09-17 13:15:03 UTC -0.1815 0.2515 650000
TRANSMEDICS GROUP INC TMDX 2021-09-17 12:45:03 UTC -0.1815 0.2515 650000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Advanced Series Trust- AST QMA U.S. Equity Alpha Portfolio TMDX -7900.0 shares, $-262122.0 2021-06-30 N-PORT
Prudential Investment Portfolios 12- PGIM QMA Large-Cap Core Equity Plus Fund TMDX -800.0 shares, $-26544.0 2021-06-30 N-PORT
Prudential Investment Portfolios 12- PGIM QMA Long-Short Equity Fund TMDX -1700.0 shares, $-56406.0 2021-06-30 N-PORT

Elevate your investments